Antiviral Agents
Chickenpox
Foscarnet
Herpes Simplex
Sprains and Strains

Foscarnet

Foscarnet is an antiviral agent used to treat cytomegalovirus (CMV), herpes simplex virus (HSV), and varicella-zoster virus (VZV) infections, particularly in immunocompromised individuals. Foscarnet is typically reserved for viral strains for which first-line treatments may be less effective. This activity examines the drug’s mechanism of action, contraindications, adverse effects, and the FDA’s boxed warnings. Pharmacokinetic properties and drug interactions will also be reviewed, providing essential knowledge for adjusting dosages to minimize adverse effects. Foscarnet requires careful management due to its nephrotoxic potential and electrolyte imbalances, among other risks. Understanding the role of an interprofessional healthcare team in monitoring and managing these adverse effects is critical for ensuring patient safety. A strong focus on adherence to evidence-based treatment protocols enhances the antiviral effectiveness of foscarnet. This activity highlights the importance of optimizing treatment regimens to improve patient outcomes with complex viral infections.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.